Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05588388
Title Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases (BELIEVE)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kamya Sankar
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA


No variant requirements are available.